Antibiotics and Human Microbial Community Dynamics
Antibiotics and Human Microbial Community Dynamics
批准号:
8975217
负责人:
DAVID A. RELMAN
金额:
$27.65万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-12-17 至 2017-11-30
关键词:
AddressAdultAffectAntibioticsCellsChemicalsCiprofloxacinColonCommunitiesComplementarity Determining RegionsComplexDNA SequenceDataData AnalysesData SetDevelopmentDietDiseaseDrug Metabolic DetoxicationEcosystemGenerationsGenesGoalsHabitatsHealthHumanHuman MicrobiomeHygieneImmune systemIndividualIndividual DifferencesInfectionIntegration Host FactorsInterventionLeadLifeMammalsMedicalMicrobeMonitorPatternPhysiologyPopulationRecombinant DNARecording of previous eventsRoleSamplingSeriesShotgunsStructureTaxonTimeTravelVariantWorkacute symptombasedeep sequencingenvironmental chemicalexperiencegut microbiotametabolomicsmicrobialmicrobial communitymicrobiotamutualismnutritionoffspringpredictive modelingrRNA Genesresilienceresponsetool
中文摘要
描述(由申请人提供):人类与一个复杂的共生微生物群共同进化,这些微生物群在一系列身体栖息地中被组织成不同的群落,我们的健康依赖于它们。在发达国家和发展中国家,这些微生物群落定期暴露于强效抗生素已成为普遍现象,这种情况在我们的进化史上是前所未有的。这种暴露导致人类微生物群组成的直接而深刻的变化。尽管这些群落的总体稳健性很明显,但抗生素引起的一些组成变化似乎是稳定的。社区的功能变化也可能发生,但几乎没有被检查过。这些变化令人担忧,因为微生物与人类宿主之间的许多有益相互作用是特定菌株所特有的;在群落内填充相同生态位的相关菌株可能与宿主没有相同的有益相互作用。对抗生素对人类-微生物相互作用的影响的理解仍然是零碎的,部分原因是用于解决这种复杂群落中的组成,功能潜力和相互作用的有效,高通量工具直到最近才出现,并且在没有干扰的情况下解决肠道微生物群组成和功能的常规时间变化的数据很少。所提出的工作的广泛、长期目标是了解人类肠道微生物群组成和功能的常规时间变化,发现影响这些群落在一个抗生素过程干扰后的稳定性和弹性(或缺乏稳定性和弹性)的因素,并表征组成和功能动态的个体间差异,以及组成和功能之间随时间的关系。具体目标在没有人为干扰的情况下,通过对10名受试者每周粪便样本中的16S rRNA基因进行深度测序,以及多变量和时间序列分析,表征健康成人36周内肠道微生物群分类组成的时间动态。具体目标2。在没有人为干扰的情况下,36周内健康成人肠道微生物群的功能基因含量和化学环境的时间动态特征,基于猎枪DNA测序和Aim 1每周粪便样本子集的代谢组学分析,以及基于多变量惯性的工具。具体目标3。基于25周内收集的20名健康受试者(第13周服用环丙沙星)每周粪便样本的16S rRNA基因深度测序、鸟枪式DNA测序和代谢组学分析,表征短期抗生素对健康成人肠道微生物群的分类组成、功能基因含量和化学环境的影响。
英文摘要
DESCRIPTION (provided by applicant): Humans have co-evolved with a complex mutualistic microbiota, organized into distinct communities in a range of body habitats, upon which we rely for our health. Periodic exposure of these microbial communities to potent antibiotics has become common in both the developed and developing world, a situation that is unprecedented in our evolutionary history. Such exposures lead to immediate, profound changes in the composition of the human microbiota. Despite the apparent overall robustness of these communities, some antibiotic-induced changes in composition appear to be stable. Functional changes in the community may also occur, but have scarcely been examined. These changes are worrisome, because many beneficial interactions between microbes and the human host are specific to particular strains; related strains that fill the same ecological niche within the community may not have the same beneficial interactions with the host. An understanding of the effects of antibiotics on human-microbe interactions remains fragmentary in part because effective, high-throughput tools for addressing the composition, functional potential and interactions within such complex communities have only recently become available, and data addressing the routine temporal variation in the composition and function of the gut microbiota in the absence of disturbance are scarce. The broad, long-term objectives of the proposed work are to understand the routine temporal variability in composition and function of the human gut microbiota, to discover factors contributing to the stability and resilience (or lack thereof) of these communities after disturbance by a course of antibiotics, and to characterize inter-individual differences in the compositional and functional dynamics, and in the relationship between composition and function over time. Specific Aim 1. Characterize the temporal dynamics of the taxonomic composition of the gut microbiota in healthy human adults over 36 weeks in the absence of deliberate disturbance, based on deep sequencing of 16S rRNA genes in weekly fecal samples in 10 subjects, and multivariate and time series analyses. Specific Aim 2. Characterize the temporal dynamics of the functional gene content and of the chemical milieu of the gut microbiota in healthy human adults over 36 weeks in the absence of deliberate disturbance, based on shotgun DNA sequencing and metabolomic analysis of a subset of the weekly fecal samples from Aim 1, and multivariate coinertia-based tools. Specific Aim 3. Characterize the impact of a short course of an antibiotic on the taxonomic composition, functional gene content, and chemical milieu of the gut microbiota in healthy human adults, based on deep sequencing of 16S rRNA genes, shotgun DNA sequencing and metabolomic analysis of weekly fecal samples from 20 healthy subjects collected over 25 weeks (with a course of ciprofloxacin during week 13).
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s40168-016-0160-7
发表时间:
2016-04-12
期刊:
Microbiome
影响因子:
15.5
作者:
[Gorvitovskaia A, Holmes SP, Huse SM]
通讯作者:
Huse SM
Household transmission of the human gut microbiota after antibiotic exposure
-
批准号:10593834
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2022
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10624323
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10176389
-
项目类别:
-
资助金额:$72.61万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Microbial dispersal, skin-to-skin contact, and assembly of the neonatal gut microbiome
-
批准号:10178070
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10404963
-
项目类别:
-
资助金额:$72.05万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8889677
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8606066
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:9113017
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Integration of Microbe and Host Data Diagnosis of Febrile Illness
-
批准号:9241962
-
项目类别:
-
资助金额:$108.16万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8579781
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:9052450
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8878218
-
项目类别:
-
资助金额:$57.57万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8672626
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8412747
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:8260250
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2011
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:7675064
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7571520
-
项目类别:
-
资助金额:$55.85万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7940507
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7691405
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7893813
-
项目类别:
-
资助金额:$58.49万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
海外基金